Valuation: Procter & Gamble Health Limited

Market Cap 90.03B 938M 824M 776M 710M 1.33B 1.34B 9.3B 3.61B 45.86B 3.52B 3.45B 149B P/E 2027 *
24.5x
P/E 2028 * 22x
Enterprise Value 90.03B 938M 824M 776M 710M 1.33B 1.34B 9.3B 3.61B 45.86B 3.52B 3.45B 149B EV / Sales 2027 *
5.82x
EV / Sales 2028 * 5.16x
Free-Float
47.81%
Yield 2027 *
2.01%
Yield 2028 * 2.18%
1 day-0.32%
1 week-0.66%
Current month-5.85%
1 month-7.04%
3 months-12.63%
6 months+12.65%
Current year-4.87%
1 week 5,408.85
Extreme 5408.85
5,549.95
1 month 5,324.4
Extreme 5324.4
5,904.95
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 69 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-0.66%-13.70%+11.57% 943M
-0.81%-0.19%+13.41%+63.37% 46.71B
-0.72%+1.24%+37.33%+106.94% 36.9B
+0.87%+6.57%+12.96%+98.17% 12.18B
+1.16%+3.02%-8.39%+17.97% 11.66B
0.00%-0.95%+20.37%+140.74% 8.97B
-1.80%+0.85%+20.51%+202.74% 7.29B
-0.16%+0.40%+26.12%+37.50% 7.21B
+0.77%+3.33%+40.01%-16.11% 7.09B
-2.45%+1.48%-44.81%+8.04% 5.12B
Average -0.35%+1.15%+10.38%+67.09% 14.41B
Weighted average by Cap. -0.43%+0.63%+18.23%+78.15%

Financials

2027 *2028 *
Net sales 15.47B 161M 142M 133M 122M 228M 230M 1.6B 621M 7.88B 606M 592M 25.62B 17.43B 182M 160M 150M 138M 257M 259M 1.8B 699M 8.88B 682M 667M 28.86B
Net income 3.67B 38.27M 33.62M 31.66M 28.96M 54.11M 54.58M 379M 147M 1.87B 144M 141M 6.08B 4.09B 42.6M 37.43M 35.24M 32.24M 60.23M 60.76M 422M 164M 2.08B 160M 156M 6.77B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
26-09-24 ₹5,423.60 -0.32% 167
26-09-23 ₹5,441.25 -0.36% 171
26-09-22 ₹5,460.75 -0.82% 291
26-09-21 ₹5,506.15 +0.08% 415
26-09-18 ₹5,502.00 +1.23% 252
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock